Exelixis announces phase 1 trial results of cabozantinib plus nivolumab in advanced genitourinary tumours
Exelixis today announced results from a phase 1 trial of [...]
Exelixis today announced results from a phase 1 trial of [...]
A study published in the European Journal of Cancer shows that [...]
A combination of the PD-1 inhibitor pembrolizumab (Keytruda) with another [...]
NHS England has today published new ratings providing a snapshot [...]
This week saw the initiation of a global phase III [...]
Researchers at the University of British Columbia have discovered how [...]
The European Commission has approved Kisplyx (lenvatinib) for the treatment [...]
The European Medicines Agency (EMA) has approved Cabometyx (cabozantinib) as [...]
The combination of vascular endothelial growth factor (VEGF)-directed and mammalian [...]
It is well known that obesity is a risk factor [...]